OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management
Clara García-Carro, Ander Vergara, Sheila Bermejo, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Obesity and chronic kidney disease
Zongmiao Jiang, Yao Wang, Xue Zhao, et al.
AJP Endocrinology and Metabolism (2022) Vol. 324, Iss. 1, pp. E24-E41
Closed Access | Times Cited: 145

Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment
Ludovica Verde, Luigi Barrea, Marilisa Galasso, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 721-721
Open Access | Times Cited: 2

Obesity‐related glomerulopathy: Current approaches and future perspectives
José Ignacio Martínez‐Montoro, Enrique Morales, Isabel Cornejo‐Pareja, et al.
Obesity Reviews (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 59

SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
Roko Škrabić, Marko Kumrić, Josip Vrdoljak, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 36

Towards an adiposity-related disease framework for the diagnosis and management of obesities
Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 795-807
Open Access | Times Cited: 19

Assessment of the impact of glyphosate and 2,4-D herbicides on the kidney injury and transcriptome changes in obese mice fed a Western diet
Guilherme Ribeiro Romualdo, Jéssica Luri Hisano de Souza, Letícia Cardoso Valente, et al.
Toxicology Letters (2023) Vol. 385, pp. 1-11
Closed Access | Times Cited: 19

Metabolic Impact of Frailty Changes Diabetes Trajectory
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2023) Vol. 13, Iss. 2, pp. 295-295
Open Access | Times Cited: 16

Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Mariam M. Ali, Sanober Parveen, Vanessa Williams, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100341-100341
Open Access | Times Cited: 7

Sex-Based Differences in Risk Factors and Complications of Chronic Kidney Disease
Melanie Wyld, Nicole De La Mata, Andrea K. Viecelli, et al.
Seminars in Nephrology (2022) Vol. 42, Iss. 2, pp. 153-169
Closed Access | Times Cited: 24

Catechins prevent obesity-induced kidney damage by modulating PPARγ/CD36 pathway and gut-kidney axis in rats
Vikram Patial, Swati Katoch, Jyoti Chhimwal, et al.
Life Sciences (2023) Vol. 316, pp. 121437-121437
Closed Access | Times Cited: 15

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives
Frederik Flindt Kreiner, Philip Andreas Schytz, Hiddo J.L. Heerspink, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2498-2498
Open Access | Times Cited: 14

Body Mass Index in Late Adolescence and Later Life Kidney Outcomes: A Population-Based Cohort Study in Swedish Men
Monika Vitkauskaitė, Ernesta Mačionienė, Rytis Stankevičius, et al.
Kidney Medicine (2025) Vol. 7, Iss. 4, pp. 100982-100982
Open Access

From fat to filter: the effect of adipose tissue-derived signals on kidney function
Nermin Ahmed, C. Dalmasso, M. Turner, et al.
Nature Reviews Nephrology (2025)
Closed Access

The Fat Kidney
Ludovica Verde, Stefania De Luca, Simona Cernea, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 2, pp. 86-98
Open Access | Times Cited: 11

Cardiovascular Disease Risk Reduction and Body Mass Index
Rohan Samson, Pierre Vladimir Ennezat, Thierry H. Le Jemtel, et al.
Current Hypertension Reports (2022) Vol. 24, Iss. 11, pp. 535-546
Closed Access | Times Cited: 18

Recent advances in the treatment of patients with obesity and chronic kidney disease
Roshaida Abdul Wahab, Ricardo V. Cohen, Carel W. le Roux
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 10

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
Jason Stencel, Hamid R. Alai, Aneesh Dhorepatil, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3341-3341
Open Access | Times Cited: 10

Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension
Luigi Petramala, Antonietta Gigante, Francesca Sarlo, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Obesidad y enfermedad cardiovascular y renal. Posicionamiento de las Asociaciones de Cardiología Preventiva, Cardiología Clínica e Insuficiencia Cardiaca de la SEC
Almudena Castro Conde, Juan José Gorgojo Martínez, J.L. Teruel, et al.
REC CardioClinics (2024) Vol. 59, Iss. 3, pp. 212-224
Closed Access | Times Cited: 3

Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype
Anna Di Sessa, Antonio Paride Passaro, Alberto Maria Colasante, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 12, pp. 1247-1255
Closed Access | Times Cited: 8

Obesity and glomerular filtration rate
Paula Schwartz, Maria Mercedes Capotondo, Miranda Quaintenne, et al.
International Urology and Nephrology (2023) Vol. 56, Iss. 5, pp. 1663-1668
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top